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Objectives The study sought to evaluate the clinical impact of angiographic complete (CR) and incomplete (ICR) revascular-
ization and its association with the presence of total occlusions (TO), after percutaneous coronary intervention
(PCI) or coronary artery bypass graft (CABG) surgery in the “all-comers” SYNTAX (Synergy Between Percutaneous
Coronary Intervention with Taxus and Cardiac Surgery) trial.
Background In patients with complex coronary artery disease undergoing PCI or CABG, the long-term prognostic implications
of CR versus ICR is unsettled.
Methods In this post hoc study, consisting of randomized (n  1,800) and nested PCI (n  198) and CABG (n  649) reg-
istries, 4-year clinical outcomes were compared in groups, with and without angiographic CR, in the PCI and
CABG arms. Clinical outcomes were analyzed with Kaplan-Meier estimates, log-rank comparisons, and Cox re-
gression analyses. Multivariate predictors of ICR were determined. Similar analyses were undertaken in the TO
and non-TO treated groups of both study arms.
Results Angiographic CR was achieved in 52.8% of the PCI arm and 66.9% of the CABG arm. Within the PCI and CABG
arms, ICR (compared with CR) seemed to be a surrogate marker of a greater burden of anatomical coronary
complexity and clinical comorbidity and was associated with significantly higher frequencies of 4-year mortality,
all-cause revascularization, stent thrombosis (PCI arm), and major adverse cardiac and cerebrovascular events.
The presence of a TO was the strongest independent predictor of ICR after PCI (hazard ratio: 2.70, 95% confi-
dence interval: 1.98 to 3.67, p  0.001). Eight hundred and forty patients (PCI: 26.3%, CABG: 36.4%, p 
0.001) were identified to have 1,007 TOs, with 68.1% of TOs located in the proximal-mid coronary vasculature.
The findings associating ICR (compared with CR) with higher frequencies of 4-year mortality and major adverse
cardiac and cerebrovascular events remained consistent in the TO-treated groups in the PCI and CABG arms.
Conclusions Within the PCI and CABG arms of the all-comers SYNTAX trial, angiographically determined ICR has a detrimen-
tal impact on long-term clinical outcomes, including mortality. This effect remained consistent in patients with
and without TOs. (J Am Coll Cardiol 2013;61:282–94) © 2013 by the American College of Cardiology
Foundation
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January 22 2013:282–94 Incomplete Angiographic RevascularizationIn patients with complex coronary artery disease—namely,
unprotected left main coronary artery (ULMCA) or de novo
3-vessel disease—undergoing coronary artery bypass graft
(CABG) surgery or percutaneous coronary intervention
(PCI), the long-term prognostic implications of complete
(CR) versus incomplete (ICR) revascularization is unsettled
(1–12). In addition, recent studies have suggested that
angiographic CR after CABG revascularization might not
be associated with a significant improvement in long-term
clinical outcomes (6,7).
The impact of successful or unsuccessful treatment of
total occlusion (TO) and its association with completeness
of revascularization in PCI- or CABG-treated patients with
ULMCA and/or multivessel disease also remains unde-
fined. Although multiple registries have associated success-
ful complete TO PCI with improved long-term mortality,
these studies were conducted in patients with less complex
coronary disease (13–17). Only 1 retrospective registry study
has examined CTO PCI in patients with predominantly
multivessel disease and associated successful CTO PCI in
the context of CR with a survival advantage, compared with
patients with ICR (18).
The purpose of this study was to report the long-term
(4-year) clinical impact of complete and incomplete angio-
graphic revascularization in the All-Comers SYNTAX
(Synergy Between Percutaneous Coronary Intervention
with Taxus and Cardiac Surgery) Trial. The All-Comers
SYNTAX Trial provided an opportunity for the assessment
of patients where selection bias in enrolling patients was
minimal and therefore was potentially more representative
of contemporary clinical practice. Secondly, the presence of
TOs to influence the ability of PCI or CABG to achieve
CR was examined, on the basis of the hypothesis that failure
to treat TOs would have a significantly detrimental impact
on long-term clinical outcomes in PCI- and CABG-treated
patients.
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The All-Comers SYNTAX Trial is a randomized, prospec-
tive, multicenter trial (n  3,075) investigating patients
with ULMCA disease (isolated
or associated with 1-, 2-, or
3-vessel disease) or de novo
3-vessel coronary artery disease
and has previously been de-
scribed (19–21). In brief, exclu-
sion criteria were appropriately
limited and consisted of patients
with prior coronary revascular-
ization, the requirement of con-
comitant cardiac surgery, or on-
going acute myocardial infarction.
During the local Heart Team
meeting, the interventional car-
diologist and cardiac surgeon
specified the number of coronary
lesions requiring treatment and
their angiographic location and
characteristics with the SYN-
TAX Score as a tool to aid in this
process (22–24). All patients
considered as potentially achiev-
ing “equivalent anatomic” revas-
cularization with percutaneous or
surgical revascularization by the
Heart Team were randomized on
a 1:1 basis (n  1,800) to either
PCI with TAXUS Express paclitaxel-eluting stents (Boston
Scientific Corporation, Natick, Massachusetts) or CABG.
Patients unsuitable for randomization were nested into PCI
(CABG ineligible patients, n  198) and CABG registries
(PCI ineligible patients, n  1,077) (Fig. 1). All random-
ized patients underwent planned follow-up. Within the
nested registries, all PCI patients and 649 randomly allo-
cated CABG patients underwent follow-up on the basis of
the original study protocol (20,21).
An independent Clinical Events Committee, including
cardiologists, cardiac surgeons, and a neurologist reviewed
all the primary clinical endpoints (20,21). Baseline and peri-
and post-procedural data were prospectively collected by the
individual participating centers. Pre-procedural left ventric-
ular ejection fraction (LVEF) was defined as the percentage
LVEF taken by transthoracic echocardiography or diagnos-
tic coronary angiogram and was categorized as good
(50%), moderate (30% to 49%), or poor (30%). Four-
year clinical outcomes were compared in groups with and
without angiographic CR in the PCI and CABG arms, with
analyses repeated in the respective TO/non-TO groups.
Clinical outcomes. Clinical outcomes included all-cause
death, cardiac death, major adverse cardiac and cerebrovas-
cular events (MACCE) (a composite of all-cause death,
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft surgery
CI  confidence interval
CR  complete
revascularization
CTO  chronic total
occlusion
CVA  cerebrovascular
accident
HR  hazard ratio
ICR  incomplete
revascularization
LVEF  left ventricular
ejection fraction
MACCE  major adverse
cardiac and
cerebrovascular events
PCI  percutaneous
coronary intervention
TO  total occlusion
ULMCA  unprotected left
main coronary artery
diseasemyocardial infarction, stroke, and all-cause revasculariza-
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occlusion. Direct comparisons between the All-Comers
PCI and CABG arms were not undertaken due to the
previously reported outcomes of the SYNTAX trial
(19,20,25,26) and the presence of greater clinical comorbid-
ity and more complex anatomical coronary disease in the
nested PCI and CABG registries, respectively, which were
the predominant reasons for entry (27,28).
SYNTAX score and TO. The calculation of the SYNTAX
Score was undertaken by the study sites and an independent
core laboratory (Cardialysis BV, Rotterdam, the Nether-
lands) blinded to the treatment assignment (22–24). The
age and angiographic characteristics of TOs were specified
as part of the SYNTAX Score calculation. The definition of
the TOs required that there was absolutely no flow through
the lesion (Thrombolysis In Myocardial Infarction flow
grade 0). Antegrade flow beyond the TO maintained by
bridging collaterals and/or ipsi-collaterals was permitted.
Figure 1 Flow Chart of Frequency of CR versus ICR in PCI and
The “All-Comers” population incorporates the randomized and nested registries of
(CABG) arms. *Of the 1,077 CABG patients, 649 were randomly allocated for follo
ICR  incomplete revascularization.Core laboratory-calculated SYNTAX Scores are reported inthis study. Procedural success rates of recanalization/bypass
of TOs were available in the electronic case records of the
randomized SYNTAX population and are reported.
Completeness of revascularization. Completeness of re-
vascularization was prospectively determined after the re-
vascularization procedure by the operator, on the basis of
the intended “equivalent anatomic” revascularization agreed
during the local Heart Team conference before revascular-
ization. The degree of revascularization was angiographic,
on the basis of segment numbering of vessels with a
diameter 1.5 mm used in the calculation of the SYNTAX
Score (22–24). The exact definition of CR defined in the
original trial protocol (NCT00114972) is detailed in the
following text.
The interventional cardiologist and surgeon during the local
Heart Team conference will specify the number of lesions
and locations requiring treatment to achieve “equivalent
Arms of “All-Comers” SYNTAX Population
rcutaneous coronary intervention (PCI) and coronary artery bypass grafting
n the basis of the original study protocol (21). CR  complete revascularization;CABG
the pe
w-up oanatomic” revascularization (decision). Complete revascu-
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January 22 2013:282–94 Incomplete Angiographic Revascularizationlarization is defined as the treatment of any lesion with more
than 50% diameter stenosis in vessels1.5 mm as estimated
on the diagnostic angiogram during the local Heart Team
conference. Outcomes will be documented by the operator
based on whether the intended equivalent anatomic revas-
cularization was achieved.
Statistical analysis. The means  SD for continuous
variables were compared with the Student t test. Binary
variables are reported as counts and/or percentages and
Baseline and Procedural Characteristics for “All-Comers” CABG anStratified by Completeness of Reva cularizationTable 1 Baseline and Pr cedu al Characteristics for “All-ComeStratified by Completeness of Revascularization
PCI (n  1,0
CR ICR
Baseline clinical characteristics
Age (yrs) 65.7 9.6 67.2 1
Male 73.4% 77.8%
BMI (kg/m2) 28.2 5.0 28.0 4
Diabetes 25.6% 34.1%
Hypertension 73.0% 75.9%
Hyperlipidemia 74.4% 79.0%
Peripheral vascular disease 8.1% 12.9%
Current smoker 18.6% 15.7%
Unstable angina 28.7% 32.4%
Prior MI 33.4% 33.7%
LVEF
Good (50%) 80.6% 71.4%
Moderate (30%–49%) 15.6% 22.7%
Poor (30%) 1.6% 2.7%
Baseline anatomical and clinical scores
SYNTAX score 26.3 10.5 32.0 1
Total Parsonnet score 8.8 7.2 10.5 8
Additive EuroSCORE 3.9 2.7 4.4 3
Logistic EuroSCORE 4.0% 5.1 5.1% 6
Anatomical characteristics
TOs present 16.9% 36.8%
Number of TOs — —
1 15.9% 31.0%
2 0.9% 5.7%
3 0.2% 0.0%
Diffuse disease or small vessels 18.9% 26.9%
Number of lesions 3.4 1.6 4.6 1
Left main disease 45.2% 33.3%
Bifurcation 58.3% 66.9%
Trifurcation 6.1% 9.2%
Aorto-ostial 16.8% 13.8%
Any thrombus 2.4% 2.8%
Heavy calcification 47.3% 54.0%
Any severe tortuosity 60.9% 72.3%
Any lesion length 20 mm 48.5% 67.8%
Left arterial dominance 16.3% 20.6%
Procedural characteristics
Total number of stents implanted 4.5 2.4 4.2 2
Total length of stents implanted (mm) 85.5 51.5 76.4 4
Post-procedural hospital stay (days) 3.6 7.1 3.7 6
Procedure time (h) 1.6 0.9 1.7 0
Values are mean  SD or %.
BMI  body mass index; CABG  coronary artery bypass graft surgery; CR  complete revascularizatio
nfarction; PCI  percutaneous coronary intervention; TO  total occlusion.compared with the chi-square test. Four-year clinical out-
comes were compared in groups with and without angio-
graphic CR and expressed as Kaplan-Meier estimates, with
curves examined visually. Comparisons were made with Cox
proportional hazard ratios (HRs) and the log-rank test. In
addition, TO and non-TO group-specific HRs for all
recorded 4-year clinical outcomes were obtained. The sig-
nificance of the interaction effect between CR versus ICR in
the PCI and CABG arms and the respective TO and
PopulationsABG and PCI Populations
CABG (n  1,541)
p Value CR ICR p Value
0.01 64.9 9.6 66.1 9.7 0.020
0.086 80.2% 79.5% 0.75
0.42 28.0 4.6 27.8 4.3 0.63
0.002 27.3% 31.1% 0.13
0.28 73.3% 79.7% 0.007
0.077 77.2% 76.3% 0.71
0.009 10.7% 14.5% 0.032
0.21 22.5% 21.0% 0.54
0.19 22.7% 31.5% 0.001
0.93 31.8% 36.7% 0.063
0.001 76.5% 72.3% 0.073
0.003 18.1% 23.4% 0.017
0.17 3.3% 3.1% 0.84
0.001 32.2 13.0 34.0 12.7 0.011
0.001 8.2 6.6 9.6 7.5 0.001
0.001 3.6 2.6 4.2 2.9 0.001
0.002 3.6% 4.1 4.6% 5.0 0.001
0.001 35.0% 40.3% 0.048
0.001 — — 0.085
— 27.3% 33.4% —
— 6.8% 6.1% —
— 0.9% 0.8% —
0.002 23.6% 30.0% 0.009
0.001 4.0 1.7 5.0 1.8 0.001
0.001 46.9% 34.0 % 0.001
0.004 63.4% 67.2% 0.15
0.049 8.8% 10.6% 0.28
0.19 16.9% 14.2% 0.18
0.74 3.9% 2.3% 0.10
0.03 53.3% 56.2% 0.30
0.001 67.8% 71.6% 0.14
0.001 61.5% 74.7% 0.001
0.066 13.4% 19.5% 0.003
0.009 — — —
0.002 — — —
0.71 8.7 5.9 9.4 9.3 0.13
0.11 3.5 1.1 3.4 1.1 0.034d PCIrs”
95)
0.5
.9
2.2
.3
.0
.4
.5
.1
3.1
.0
.9n; ICR  incomplete revascularization; LVEF  left ventricular ejection fraction; MI  myocardial
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was undertaken to assess whether the HR of all 4-year
clinical outcomes for CR versus ICR was different across the
TO and non-TO groups.
Binary logistic regression analyses were undertaken to
identify univariate predictors of ICR with baseline char-
acteristics (20) and components of the SYNTAX Score,
respectively. The variables examined are detailed in Table 1.
The SYNTAX Score was excluded from these analyses to
allow for the appropriate identification of its components
(e.g., TO, calcification) associated with ICR. Univariate
predictors of ICR were entered into a multivariable model.
The enter method was implemented to determine indepen-
Figure 2 Four-Year Clinical Outcomes in Patients by Complete
Comparisons (Kaplan-Meier analyses) of 4-year clinical outcomes by completeness
grafting (B) populations. CVA  cerebrovascular accident; MACCE  major adversdent predictors, with a variable entry/stay criteria of 0.05/
0.1. Similar analyses for ICR were repeated in the TO
treated groups. A 2-sided p value  0.05 was considered
significant for all tests. Analyses were conducted with SPSS
(version 19.0, SPSS, Inc., Chicago Illinois) and STATA
(version 11.0, StataCorp, College Station, Texas).
Results
Baseline characteristics of the randomized and nested reg-
istry arms (All-Comers population) of the SYNTAX Trial
have previously been described (20,28). Within the All-
Comers population (n  2,636), angiographic CR was
s Incomplete Revascularization
vascularization in the All-Comers PCI (A) and All-Comers coronary artery bypass
iac and cerebrovascular events; MI  myocardial infarction.Versu
of re
e card
*T
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January 22 2013:282–94 Incomplete Angiographic Revascularizationachieved in 52.8% of the PCI arm (n  1,095) and 66.9%
of the CABG arm (n  1,541) (Fig. 1).
Baseline and procedural characteristics on the basis of
CR and ICR. Baseline and procedural characteristics of
CR and ICR in the PCI (n  1,095) and CABG (n 
1,541) arms are shown (Table 1). Within the PCI and
CABG arms, more anatomically complex disease (higher
SYNTAX Score)—including the presence of TOs, greater
clinical comorbidity (higher EuroSCORE [29] and Parsonnet
Score [30]), and a reduced prevalence of ULMCA disease—
were evident in patients with ICR compared with CR.
Clinical outcomes on the basis of completeness of revas-
cularization. Within the PCI and CABG arms, ICR (com-
pared with CR) was associated with significantly higher
frequencies of 4-year mortality, all-cause revascularization,
stent thrombosis (PCI arm), and MACCE (Fig. 2).
Predictors of ICR. Multivariate analyses of ICR in the
PCI and CABG arms are shown (Table 2). The strongest
independent predictor of ICR in the PCI arm was the
presence of a TO (HR: 2.70, 95% confidence interval [CI]:
1.98 to 3.67, p  0.001). The strongest independent
predictor of ICR in the CABG arm was left arterial
dominance (HR: 2.19, 95% CI: 1.05 to 4.57, p  0.038).
Left arterial dominance, any right coronary artery lesion,
number of lesions, and clinical variables (EuroSCORE/
Parsonnet Score) were common independent predictors of
ICR in the PCI and CABG arms.
TO. Baseline and procedural characteristics of patients
with and without TOs in the PCI (n  1,095) and CABG
(n  1,541) arms are shown (Table 3). Eight hundred and
Independent Predictors of ICR inAll-Comers PCI and CABG PopulationsTable 2 Ind pendent Predictors of ICR inAll-Comers PCI and CABG Populations
Anatomical/Clinical Characteristic OR (95% CI) p Value
PCI-treated patients
TO 2.70 (1.98–3.67) 0.001
Any RCA lesion 2.12 (1.33–3.38) 0.002
Left arterial dominance 1.81 (1.26–2.60) 0.001
Additive EuroSCORE 6 1.58 (1.18–2.13) 0.002
Number of lesions* 1.44 (1.29–1.59) 0.001
Hyperlipidemia 1.49 (1.08–2.06) 0.015
Any tortuosity 1.39 (1.04–1.86) 0.025
Total bifurcation/trifurcations* 1.32 (1.13–1.53) 0.001
CABG-treated patients*
Left arterial dominance 1.99 (1.45–2.73) 0.001
Any RCA lesion 1.89 (1.16–3.06) 0.010
Unstable angina 1.59 (1.23–2.05) 0.001
Peripheral vascular disease 1.34 (0.95–1.88) 0.092
Number of lesions* 1.30 (1.21–1.40) 0.001
Parsonnet score* 1.02 (1.00–1.04) 0.027
Left main coronary artery disease 0.70 (0.55–0.90) 0.005
Independent predictors of ICR in the All-Comers PCI (n 1095) and CABG (n 1541) populations.
Continuous variables/unit increase.
CI confidence interval; OR odds ratio; RCA right coronary artery; other abbreviations as in
able 1.forty patients (PCI: 26.3%, CABG: 36.4%, p 0.001) wereidentified to have 1,007 TOs. All patients with TOs (PCI
and CABG arms) were significantly more likely to have had
a previous myocardial infarction, a lower LVEF, diffuse or
small vessel disease, more coronary lesions, lesion length
20 mm, and a reduced prevalence of ULMCA disease.
Patients with TOs were less likely to achieve CR in the PCI
and CABG arms (CR PCI: non-TO 59.8%, TO 34.3%,
p  0.001; CR CABG: non-TO 69.8%, TO 64.8%, p 
0.048).
Table 4 shows the baseline angiographic characteristics of
the TOs in the entire SYNTAX population and PCI and
CABG arms. The age of the TOs was documented as 3
months or unknown in 95.6% of the study population.
Approximately two-thirds of TOs (68.1%) were located in
the proximal-mid coronary vessels on coronary angiography
(Fig. 3).
Procedural success rates of TO. Figure 4 demonstrates
the procedural success rates of TOs (n  543) on an
intention to treat basis by the study sites in the randomized
SYNTAX population. More TOs were successfully treated
with CABG compared with PCI (68.1% vs. 49.4%, p 
0.001).
Clinical outcomes on the basis of completeness of revas-
cularization in the TO groups. Figure 5 demonstrates com-
parisons of HRs for CR versus ICR in the PCI and CABG
arms for all 4-year clinical endpoints in the respective TO
and non-TO groups. The findings associating ICR (com-
pared with CR) with higher frequencies of 4-year adverse
clinical outcomes, as seen in the CABG and PCI arms of
the SYNTAX population, remained consistent in the re-
spective TO groups (nonsignificant p values for interaction),
with a few notable exceptions.
Within the PCI arm (p value for interaction 0.001),
CR in patients with TOs was associated with substantially
fewer episodes of 4-year stent thrombosis compared with
ICR (CR: 0%, n  0; ICR: 4.6%, n  7; no HR available
as 0 events in patients with CR) (Fig. 5). Within the CABG
arm (p value for interaction  0.0008), CR in patients with
TOs was related to a significantly lower risk of 4-year graft
occlusion, compared with ICR (CR 2.7% vs. ICR 7.6%;
HR: 0.34, 95% CI: 0.14 to 0.84, p  0.019); conversely, in
patients with CR without TOs, the risk of 4-year graft
occlusion was substantially higher (CR 5.2% vs. ICR 0.86%;
HR: 6.22, 95% CI: 1.49 to 26.07, p  0.012).
Despite limitations of power in the TO groups, signifi-
cant reductions in 4-year MACCE were evident in patients
with TOs who achieved CR (vs. ICR) treated with either
PCI or CABG (Fig. 6).
Predictors of ICR in TO groups. Table 5 lists indepen-
dent predictors of ICR in the TO groups of PCI- and
CABG-treated patients. Within the cohort of TO treated
PCI patients, heavy calcification and long lesions were
additional independent predictors of ICR compared with
the main study findings (Table 2).
288 Farooq et al. JACC Vol. 61, No. 3, 2013
Incomplete Angiographic Revascularization January 22 2013:282–94Discussion
In this post hoc study of the All-Comers SYNTAX Trial,
there were several notable findings. First, within the PCI
and CABG arms, ICR (compared with CR) seemed to be
a surrogate marker of a greater burden of anatomical
coronary complexity and clinical comorbidity and was asso-
ciated with a significant increase in 4-year mortality, all-
cause revascularization, MACCE, and stent thrombosis
(PCI arm). Second, the presence of a TO was less likely to
Baseline and Procedural Characteristics for All-Comers PCI and CATable 3 Baseline and Procedural Characteristics for All-Comers
PCI (n  1,0
Non-TO TO
Baseline clinical characteristics
Age (yrs) 66.4 9.9 65.9
Male 74.6% 77.6
BMI (kg/m2) 28.0 4.8 28.5
Diabetes 28.9% 31.5
Hypertension 73.7% 75.7
Hyperlipidemia 75.8% 79.4
Peripheral vascular disease 9.9% 11.5
Current smoker 17.9% 15.1
Unstable angina 29.9% 31.8
Prior MI 31.4% 39.4
LVEF
Good (50%) 80.3% 65.0
Moderate (30%–49%) 16.5% 25.9
Poor (30%) 1.0% 5.2
Baseline clinical scores
Total Parsonnet score 9.5 7.8 9.9
Additive EuroSCORE 4.1 2.7 4.3
Logistic EuroSCORE 4.2% 5.1 5.2%
Anatomical characteristics
Number of TOs — —
1 — 87.8
2 — 11.9
3 — 0.3
Diffuse disease or small vessels 20.9% 26.9
Number of lesions 3.9 1.7 4.2
Left main disease 44.1% 26.9
Bifurcation 61.9% 63.6
Trifurcation 8.4% 4.9
Aorto-ostial 16.0% 15.0
Any thrombus 2.5% 2.8
Heavy calcification 49.4% 52.4
Any severe tortuosity 65.5% 67.5
Left dominance 17.8% 18.9
Procedural characteristics
Lesion length 20 mm 49.0% 80.8
Total number of stents implanted 4.4 2.3 4.4
Total length of stents implanted (mm) 80.6 49.1 84.2
Post-procedural hospital stay (days) 3.6 7.1 3.8
Procedure time (h) 1.6 0.9 1.7
Completeness of revascularization
Complete revascularization 59.8% 34.3
Values are mean  SD or %.
Abbreviations as in Table 1.result in CR in the PCI and CABG arms, with this effectbeing substantially more pronounced in the PCI arm, where
the presence of a TO was shown to be the strongest
independent predictor of ICR. Third, ICR (compared with
CR) was associated with poorer clinical outcomes (4-year
mortality and MACCE) across the TO and non-TO
groups.
The low rate of CR in the PCI arm (34.3%) compared
with the CABG arm (64.8%) was predominantly related to
the lack of procedural success of TO PCI, as evident by a
nd Populations Stratified by the Presence of TOsand CABG and Populations Stratified by the Presence of TOs
CABG (n  1,541)
p Value Non-TO TO p Value
0.47 65.4 9.4 64.9 10.0 0.31
0.31 76.8% 84.7% 0.001
0.17 27.8 4.5 28.3 4.7 0.04
0.41 28.0% 30.9% 0.24
0.50 75.7% 75.0% 0.76
0.21 76.5% 78.3% 0.44
0.43 10.2% 14.8% 0.008
0.29 21.7% 22.6% 0.67
0.54 27.1% 22.6% 0.051
0.015 30.3% 39.7% 0.001
0.001 81.6% 64.4% 0.001
0.001 15.2% 27.1% 0.001
0.001 2.2% 5.4% 0.001
0.42 8.5 7.0 8.9 6.9 0.30
0.27 3.8 2.7 3.8 2.7 0.96
0.047 3.9% 4.3 4.0% 4.6 0.72
— — — —
— — 79.8% —
— — 17.9% —
— — 2.4% —
0.035 20.9% 33.0% 0.001
0.001 4.2 1.9 4.7 1.6 0.001
0.001 48.0% 32.9% 0.001
0.60 65.7% 63.4% 0.36
0.055 10.0% 8.8% 0.45
0.70 18.2% 12.5% 0.003
0.79 3.9% 2.7% 0.21
0.37 52.7% 56.5% 0.16
0.54 68.7% 70.4% 0.48
0.37 15.9% 14.8% 0.16
0.001 53.1% 87.2% 0.001
0.82 — — —
0.29 — — —
0.63 8.8 5.7 9.2 9.1 0.30
0.012 3.5 1.1 3.6 1.0 0.025
0.001 69.8% 64.8% 0.048BG aPCI
95)
10.6
%
5.2
%
%
%
%
%
%
%
%
%
%
7.9
3.1
7.4
%
%
%
%
1.3
%
%
%
%
%
%
%
%
%
2.0
44.3
5.2
1.0
%49.4% recanalization rate in the randomized SYNTAX
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in the CABG arm) on an intention-to-treat basis (Fig. 4).
Furthermore, the clinical impact of failure to recanalize TOs
by PCI would potentially have been greater, because two-
thirds of TOs were located in the proximal-mid coronary
major epicardial vessels (Fig. 3). Comparatively, other
anatomical factors associated with ICR in the PCI and
CABG arms might be of lesser importance, because the
amount of jeopardized myocardium would have been lower
compared with a TO—for example, a diseased side branch
of a coronary bifurcation. Previous studies have shown that
myocardial territory with 10% reversible ischemia derives
he greatest clinical benefit from revascularization (31–33).
In the CABG arm, CR was achieved less frequently in
atients with TOs compared with patients without TOs
Baseline Angiographic Characteristics of TOs onP rameters From SYNTAX Score Calculation FroTable 4 Baseline Angiograph c CharacteristParameters From SYNTAX Score Ca
SYNTAX Score Parameter for TO on Lesion Level in
All-Comers SYNTAX Trial*
Age of TO
3 months/unknown
3 months
Blunt stump
Bridging occlusion
Ostial lesion
Severe tortuosity
Heavy calcification
Thrombus
Length 20 mm
Non-visible segments beyond TO†
Side-branch at the origin of the TO
No
Yes, side-branches 1.5mm
Yes side-branches 1.5 mm
Baseline angiographic characteristics of the TOs on the basis of param
(n  2,636) (22–24). Lesion level data shown (n  1,007). Percenta
(diameter stenosis 50% in vessels 1.5 mm) 3 vessel reference d
Abbreviations as in Table 1.
Figure 3 Location of Total Occlusions in All-Comers SYNTAX P
Total occlusions (n  1,007 lesions) in the All-Comers SYNTAX population (n  2
accounted for over two-thirds (68.1%) of total occlusions.(non-TO: 69.8%, TO: 64.8%, p  0.048). Notably, a
similar phenomenon was reported in the ARTS (Arterial
Revascularization Therapies Study) (34). A potential expla-
nation for this finding might be related to the presence of a
TO being associated with more diffuse or small vessel
disease (non-TO: 20.9%, TO: 33.0%, p  0.001) and
consequently hindering the anastomosis of a bypass graft
distally (Fig. 4).
Completeness of revascularization. One of the reasons
the long-term prognostic implications of completeness of
revascularization has historically remained controversial
has been a lack of consistency in the definition of ICR
(1,4 – 6,8,10,11). For example, variations in the size of
coronary vessels included and diameter stenosis on the basis
of coronary angiography have made results difficult to
Basis ofl-Comers SYNTAX Trialf TOs on the Basis of
tion From All-Comers SYNTAX Trial
ated TOs
1,007)
PCI-Treated TOs
(n  324)
CABG-Treated TOs
(n  683)
(95.6%) 304 (93.8%) 659 (96.5%)
(3.4%) 20 (6.2%) 24 (3.5%)
(22.9%) 78 (24.1%) 153 (22.4%)
(10.4%) 40 (12.3%) 65 (9.5%)
(3.4%) 12 (3.7%) 22 (3.2%)
(22.2%) 77 (23.8%) 147 (21.5%)
(23.9%) 71 (21.9%) 170 (24.9%)
(0.7%) 2 (0.6%) 5 (0.7%)
(64.3%) 192 (59.3%) 455 (66.6%)
(22.4%) 85 (26.2%) 141 (20.6%)
(31.5%) 110 (34.0%) 207 (30.3%)
(50.8%) 158 (48.8%) 354 (51.8%)
(20.7%) 66 (20.4%) 142 (20.8%)
rom the SYNTAX Score calculation from the All-Comers SYNTAX Trial
te to proportions/column. *Analyzed lesions include serial stenoses
rs apart. †Visualized by antegrade or retrograde contrast.
tion
Left main, proximal, and mid vessels (highlighted in red)them Alics o
lcula
All Tre
(n 
963
44
231
105
34
224
241
7
647
226
317
512
208
eters f
ges relaopula
,636).
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ical endpoints, quality of clinical endpoint monitoring and
adjudication, and selection biases in observational registries
have compounded this issue (1,5).
The strength of the present study was that the
angiographic-based definition of CR/ICR was prospectively
and rigorously systematically applied across all PCI- and
CABG-treated patients in an All-Comers setting. Al-
though more anatomically complex patients were enrolled
into the nested CABG registry and more with clinical
comorbidity were enrolled in the nested PCI registry
(27,28), this is representative of contemporary clinical prac-
tice. Within the present study, the decision to use a 1.5-mm
vessel as the minimum size of vessel that could be revascu-
larized was devised during the design of the SYNTAX Trial
to reflect the ability of the cardiac surgeon to anastomose
bypass grafts to vessels of this size. To allow appropriate
randomization of the patient, the interventional cardiologist
was required to match this practice.
In patients treated with PCI or CABG, ICR seemed to
be a surrogate marker of a greater burden of anatomical
Figure 4 Treatment of Total Occlusions on an Intention to Trea
*Specified as “total occlusion” on the electronic case records without specific rea
Abbreviations as in Figure 1.coronary complexity and clinical comorbidity and was asso-ciated with a poorer long-term prognosis in PCI- and
CABG-treated patients. These findings are not unexpected,
given the historical association of more extensive baseline
preoperative coronary disease with reduced long-term sur-
vival in the CASS (Coronary Artery Surgery Study) (35)
and Rotterdam (36) registries. Furthermore, within the
BARI (Bypass Angioplasty Revascularization Investigation)
trial (37)—consisting of patients treated with PCI or
CABG who underwent entry and 5-year coronary angio-
graphic follow-up—native coronary disease progression
(and not the extent of initial revascularization) was shown to
be the predominant determinant of recurrence of angina and
jeopardized myocardium at 5 years. Notably in this study,
two-thirds of the increase in myocardial jeopardy was in
previously untreated coronary vessels.
Moreover, the findings of the present study directly
contradict that reported from the 3-year randomized
SYNTAX trial (7), where no differences in clinical out-
comes between CR and ICR were seen in the CABG
population. Similar findings were shown in the 4-year
randomized data (unpublished data). The disparity in re-
is by Study Sites in Randomized SYNTAX Population
ven for unsuccessful treatment of total occlusion.t Bas
son gisults seems to reflect the fact that the nested CABG registry
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January 22 2013:282–94 Incomplete Angiographic RevascularizationFigure 5 Four-Year Clinical Outcomes in Patients Stratified by Presence of CR and ICR With and Without TOs
Hazard ratios (HR) represent CR versus ICR for each 4-year clinical endpoint. A nonsignificant p value for interaction indicates that the HR of CR versus ICR in the PCI
and CABG arms remained similar across the respective TO and non-TO groups. CI  confidence interval; Revasc  revascularization; TO  total occlusion; other abbrevi-
ations as in Figures 1 and 2.
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with the randomized CABG cohort (SYNTAX Score:
nested CABG registry 37.8  13.3, randomized CABG
9.1  11.4, p  0.002) (27,28). The ICR in the All-
omers CABG population therefore potentially resulted in
ore jeopardized myocardium, secondary to more anatom-
cally complex coronary artery disease and greater clinical
omorbidity (higher EuroSCORE and Parsonnet Scores)
nd their association with a likely increase in coronary
therosclerotic burden (4) and adverse long-term clinical
utcomes as previously discussed. Within the PCI arm,
otentially more jeopardized myocardium remained in pa-
ients with ICR compared with CABG, secondary to the
ailure to recanalize TOs or other (perhaps lesser important)
Figure 6 Four-Year MACCE Stratified by
Presence of ICR Versus CR in Patients With TOs
A significant increase in MACCE was evident in PCI- and CABG-treated TO
patients with ICR. These findings reflect the findings seen in both the PCI and
CABG arms, where ICR was associated with poorer 4-year clinical outcomes
compared with CR (Fig. 2). Abbreviations as in Figures 1 and 2.natomical factors, such as the presence of bifurcations, inddition to the similar factors associated with ICR in
ABG patients.
linical impact of PCI- and CABG-treated TO. Beyond
he main study findings of increased stent thrombosis
ssociated with ICR in the PCI arm (CR 3.7%, ICR 6.5%,
 0.046), further analyses indicated that there was a
ubstantial increase in stent thrombosis in patients with
Os who had ICR (CR: 0 episodes [0%], ICR: 7 episodes
4.6%]). Notably, patients with ICR had fewer stents (p 
.009) and shorter total length of stents implanted (p 
.002) (Table 1). Attempting to understand the mecha-
isms underlying this possible phenomenon are speculative.
s to whether episodes of stent thrombosis are secondary to
eoatherosclerosis (38) related to the more adverse clinical
omorbidity in patients with ICR: stent under-deployment
ue to greater coronary calcification associated with ICR,
ailure to fully expand a TO after successful coronary wire
assage (Fig. 4), or the potential risk of delayed re-
ndothelialization—particularly if a subintimal technique of
oronary wire passage is undertaken (39)—are all hypothet-
cal mechanisms that require further study.
In the present study, the graft occlusion rate was substan-
ially lower when CR was achieved in patients with TOs
and greater when CR was achieved in patients without
Os). These findings are consistent with previous studies,
here early graft failure has been shown to be higher when
nastomosed to functionally nonsignificant lesions or where
ompetitive filling with the treated native vessel is seen
40–43).
otential recommendations. Recently the concept of “rea-
onable” or “appropriate” ICR has been highlighted (1,3–5).
his is either anatomically guided, on the basis of revascu-
arizing most of the major epicardial vessels, or functionally/
hysiologically guided (on the basis of the burden of residual
schemia). The underlying principle is that, even if CR was
echnically possible and achievable (i.e., in all vessels 1.5
m in diameter), this would not necessarily improve clinical
utcomes—given the small territory a small side branch
ould, for example, supply. Future studies, possibly using a
Independent Predictors of ICR in TO PatientsWithin All-Com rs PCI and CABG PopulationsTable 5 Independent Pred ctors of ICR in TO PatientsWithin All-Comers PCI and CABG Populations
Anatomical/Clinical Characteristic OR (95% CI) p Value
PCI-treated TO patients
Left arterial dominance 2.19 (1.05–4.57) 0.038
Additive EuroSCORE 6 2.13 (1.16–3.88) 0.014
Any heavy calcification 2.02 (1.19–3.43) 0.009
Any lesion 20 mm 1.84 (0.96–3.53) 0.068
Total bifurcations/trifurcations* 1.37 (0.98–1.91) 0.067
Number of lesions* 1.36 (1.09–1.71) 0.006
CABG-treated TO patients
Left arterial dominance 2.50 (1.53–4.09) 0.001
Number of lesions* 1.25 (1.11–1.40) 0.001
Parsonnet score* 1.03 (1.01–1.06) 0.013PCI (n  554) and CABG (n  554) populations. *Continuous variables/unit increase.
Abbreviations as in Tables 1 and 2.
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distinguish what acceptable level of revascularization is appro-
priate that would have a significant impact on long-term
clinical outcomes. The newly devised Residual SYNTAX (46)
and CABG SYNTAX (47) Scores each allows for more
objective assessment of the degree of revascularization and
residual anatomical disease complexity post-PCI or -CABG.
Use of these methodologies might in the future aid in deter-
mining a “reasonable” threshold of revascularization.
Study limitations. The present study represents a post hoc
analysis of the SYNTAX trial, and the results should be
considered as hypothesis-generating. There was limited
statistical power in the TO-treated patients and for the
comparison of low-frequency events, such as stroke, graft
occlusion, and stent thrombosis. The age of TOs could not
be clearly defined, with most cases being unknown. Further
procedural details of recanalization of TOs are not available
beyond what is reported in the study. Core laboratory
assessment of CR/ICR was not undertaken, because no
post-operative (CABG) coronary angiograms were man-
dated in the SYNTAX trial. The possibility of other
unmeasured adverse clinical characteristics to have con-
founded the data toward ICR cannot be excluded, although
the intention of the study was to achieve CR in all study
patients. The “All-Comers” concept of the SYNTAX trial,
although more representative of contemporary clinical prac-
tice compared with the randomized approach, has been
reported to potentially not result in the inclusion of consec-
utive patients, predominantly due to the inability to gain
appropriate informed consent and refusal to participate
(48,49). Although the SYNTAX trial was based on con-
temporary revascularization practice at the time, improve-
ments in technology in PCI and CABG might yield
differences in clinical outcomes in future trials.
Conclusions
Within the PCI and CABG arms of the All-Comers
SYNTAX Trial, angiographically determined ICR seemed
to be a surrogate marker of a greater burden of anatomical
coronary complexity and clinical comorbidity and had a
detrimental impact on long-term clinical outcomes, includ-
ing mortality. This effect remained consistent in patients
with and without TOs.
The impact of ICR on clinical outcomes is dependent
on the complexity of coronary disease and risk profile of
the study population, on the basis of the observations
associating ICR with: 1) no effect on long-term clinical
outcomes (randomized CABG population); and 2) more
adverse long-term clinical outcomes (All-Comers CABG
population).
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